We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-4.95%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.9B
AUM Growth
-$320M
Cap. Flow
-$202M
Cap. Flow %
-10.62%
Top 10 Hldgs %
7.71%
Holding
2,190
New
419
Increased
603
Reduced
646
Closed
510

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$17.7M
2
SBUX icon
Starbucks
SBUX
+$16.5M
3
WMB icon
Williams Companies
WMB
+$15.6M
4
HRI icon
Herc Holdings
HRI
+$14.9M
5
DAL icon
Delta Air Lines
DAL
+$14M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$24.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$15.2M
3
TJX icon
TJX Companies
TJX
+$14.9M
4
DD
Du Pont De Nemours E I
DD
+$14.4M
5
CTRA
Coterra Energy
CTRA
+$14.2M

Sector Composition

Rank Sector Weight
1 Healthcare 14.76%
2 Consumer Discretionary 13.95%
3 Industrials 12.6%
4 Technology 11%
5 Energy 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXAS
276
DELISTED
Abraxas Petroleum Corp
AXAS
$1.56M 0.08%
14,767
+592
+4% +$66.2K
BG icon
277
Bunge Global
BG
$20.2B
$1.55M 0.08%
18,464
-37,319
-67% -$3.01M
NS
278
DELISTED
NuStar Energy L.P.
NS
$1.55M 0.08%
23,588
-5,195
-18% -$337K
CVD
279
DELISTED
COVANCE INC.
CVD
$1.55M 0.08%
19,724
-9,625
-33% -$818K
QUAD icon
280
Quad
QUAD
$559M
$1.55M 0.08%
80,508
+15,677
+24% +$339K
GD icon
281
General Dynamics
GD
$103B
$1.55M 0.08%
12,186
+3,425
+39% +$416K
PMC
282
DELISTED
PharMerica Corporation
PMC
$1.55M 0.08%
63,367
+17,284
+38% +$458K
CA
283
DELISTED
CA, Inc.
CA
$1.55M 0.08%
55,386
-158,477
-74% -$4.53M
OMC icon
284
Omnicom Group
OMC
$21.7B
$1.55M 0.08%
22,453
+14,827
+194% +$1.06M
MBI icon
285
MBIA
MBI
$266M
$1.54M 0.08%
167,950
+14,794
+10% +$145K
SCHW
286
Charles Schwab
SCHW
$184B
$1.54M 0.08%
52,415
-41,114
-44% -$1.16M
TMO icon
287
Thermo Fisher Scientific
TMO
$213B
$1.53M 0.08%
12,608
-20,966
-62% -$2.55M
MED icon
288
Medifast
MED
$108M
$1.53M 0.08%
46,580
+10,600
+29% +$325K
TSN icon
289
Tyson Foods
TSN
$21B
$1.52M 0.08%
38,677
-14,846
-28% -$568K
DALN
290
DELISTED
DallasNews
DALN
$1.52M 0.08%
35,640
-1,178
-3% -$52.7K
CELG
291
DELISTED
Celgene Corp
CELG
$1.51M 0.08%
+15,972
New +$1.44M
SEM
292
DELISTED
Select Medical
SEM
$1.5M 0.08%
+232,148
New +$1.79M
CIT
293
DELISTED
CIT Group Inc.
CIT
$1.5M 0.08%
32,756
+14,523
+80% +$688K
RJF icon
294
Raymond James Financial
RJF
$34.1B
$1.5M 0.08%
+42,026
New +$1.47M
MANH icon
295
Manhattan Associates
MANH
$10.9B
$1.5M 0.08%
44,745
+14,849
+50% +$464K
STLD icon
296
Steel Dynamics
STLD
$37B
$1.49M 0.08%
66,082
-51,301
-44% -$1.12M
AIG icon
297
American International
AIG
$41.8B
$1.49M 0.08%
27,646
-12,167
-31% -$665K
DDD icon
298
3D Systems Corp
DDD
$462M
$1.49M 0.08%
+32,208
New +$1.68M
MHFI
299
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$1.49M 0.08%
17,662
-5,561
-24% -$457K
DOX icon
300
Amdocs
DOX
$5.88B
$1.49M 0.08%
32,506
-28,002
-46% -$1.31M
10 11
12
13 14

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, GSA Capital Partners held 2,190 positions worth $1.9B, down 14% from $2.22B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

GSA Capital Partners withdrew a net $202M in Q3 2014, closing 510 positions and reducing 646 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Illumina worth $16.9M.

  • GSA Capital Partners's largest Q3 2014 buy was Illumina: 105,983 shares worth $16.9M.
  • GSA Capital Partners added most to Williams Companies in Q3 2014, an estimated $15.6M increase.
  • GSA Capital Partners's biggest Q3 2014 reduction was Marathon Petroleum, cutting an estimated $24.9M.
  • GSA Capital Partners fully exited Regeneron Pharmaceuticals in Q3 2014, selling an estimated $15.2M.
  • GSA Capital Partners's ten largest holdings make up 7.7% of its $1.9B portfolio in Q3 2014.
  • GSA Capital Partners opened 419 new positions and closed 510 in Q3 2014.
  • GSA Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.9B.

Based on GSA Capital Partners's 13F filing for Q3 2014, filed 6 Nov 2014.